adenosine monophosphate has been researched along with Heart Disease, Ischemic in 48 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 13 (27.08) | 18.2507 |
2000's | 19 (39.58) | 29.6817 |
2010's | 16 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Levi, B | 1 |
Bhatt, DL; Deliargyris, EN; Généreux, P; Gibson, CM; Hamm, CW; Harrington, RA; Mahaffey, KW; Prats, J; Price, MJ; Steg, PG; Stone, GW; White, HD | 1 |
Abtan, J; Bhatt, DL; Deliargyris, EN; Ducrocq, G; Gibson, CM; Hamm, CW; Harrington, RA; Mahaffey, KW; Prats, J; Price, MJ; Steg, PG; Stone, GW; White, HD | 1 |
Hillis, LD; Lange, RA | 1 |
Angiolillo, DJ; Bhatt, DL; Bramucci, E; Gallup, D; Généreux, P; Gibson, CM; Hamm, CW; Harrington, RA; Leonardi, S; Liu, T; Mahaffey, KW; McLaurin, BT; Prats, J; Price, MJ; Radke, PW; Skerjanec, S; Spriggs, D; Steg, PG; Stone, GW; Tauth, J; Todd, M; Tousek, F; White, HD; Widimský, P | 1 |
Riezebos, RK; Verheugt, FW | 1 |
Bhatt, DL; Harrington, RA | 1 |
Wong, BY | 1 |
Mehta, SR | 1 |
Bhatt, DL; Day, JR; French, WJ; Gibson, CM; Gogia, HS; Gruberg, L; Hamm, CW; Harrington, RA; Iwaoka, RS; Leonardi, S; Liu, T; Mahaffey, KW; Skerjanec, S; Steg, PG; Stone, GW; Stuckey, TD; White, HD | 1 |
Guo, YJ; Li, XL; Liu, JX | 1 |
Adachi, N; Dote, K; Nagaro, T; Nakanishi, K; Namba, C; Yorozuya, T | 1 |
Bell, RM; Cohen, MV; Downey, JM; Kunuthur, SP; Sivaraman, V; Yellon, DM | 1 |
Bhatt, DL; Blankenship, JC; Deliargyris, EN; Généreux, P; Gibson, CM; Gutierrez, JA; Hamm, CW; Harrington, RA; Mahaffey, KW; Prats, J; Price, MJ; Steg, PG; Stone, GW; White, HD | 1 |
Hui, Y; Kondo, K; Mochizuki, T; Sato, S; Umemura, K | 1 |
Caglayan, E; Er, F; Erdmann, E; Gassanov, N | 1 |
Bhatt, DL; Chew, DP; Dauerman, HL; Gibson, CM; Gruberg, L; Harrington, RA; Mahaffey, KW; Stone, GW; White, HD | 1 |
Heptinstall, S; Judge, HM; Storey, RF; Wilcox, RG | 1 |
Heptinstall, S; Storey, RF; Wilcox, RG | 1 |
Nurden, AT; Nurden, P | 1 |
Bacci, ML; Bach, FH; Bracco, A; Calise, F; Cozzi, E; D'Alise, G; Di Florio, E; Forni, M; Froio, A; Giovannoni, R; Lavitrano, M; Maccherini, M; Mancini, A; Musumeci, A; Otterbein, LE; Patti, M; Simeone, F; Slominska, E; Smolenski, RT; Stassi, G; Yacoub, MH | 1 |
Braun, N; Buchheiser, A; Decking, UK; Ding, Z; Flögel, U; Gear, A; Gödecke, A; Huo, Y; Koszalka, P; Ley, K; Molojavyi, A; Ozüyaman, B; Schrader, J; Sévigny, J; Smith, ML; Weber, AA; Weber, C; Zernecke, A; Zimmermann, H | 1 |
Aleil, B; Cazenave, JP; Gachet, C; Heitz, A; Ravanat, C; Rochoux, G | 1 |
Baron, SJ; Hurley, RL; Li, J; Miller, EJ; Neumann, D; Russell, RR; Tuerk, R; Wallimann, T; Witters, LA; Young, LH | 1 |
Alessi, DR; Ashworth, A; Bertrand, L; Budas, GR; Dutta, A; Jovanović, A; Pouleur, AC; Prescott, AR; Sakamoto, K; Vanoverschelde, JL; Zarrinpashneh, E | 1 |
Carling, D; Heath, R; Horman, S; Hue, L; Mouton, V; Neumann, D; Rider, MH; Schlattner, U; Vertommen, D; Wallimann, T; Woods, A | 1 |
Berriz, GF; Gerszten, RE; Heller, E; Liu, E; McCarroll, R; Morrow, DA; Roth, FP; Sabatine, MS; Wiegand, R | 1 |
Gurbel, PA; Tantry, US | 1 |
Lorentz, W; McCulloch, A; Michailova, A | 1 |
Bast, P; Dzeja, PP; Pucar, D; Terzic, A; Wieringa, B | 1 |
Clanachan, AS; Fraser, H; Omar, MA | 1 |
Bullough, D; Galiñanes, M; Hearse, DJ; Mullane, KM; Zhai, X | 1 |
Bradamante, S; Bünger, R; Cargnoni, A; Ceconi, C; Curello, S; de Jong, JW; Ferrari, R; Janssen, M; Pasini, E | 1 |
Abiko, Y; Ichihara, K; Kamigaki, M | 1 |
Torrance, SM; Wittnich, C | 1 |
Carson, S; Hayashida, N; Ikonomidis, JS; Ivanov, J; Mickle, DA; Mohabeer, MK; Tumiati, LC; Weisel, RD; Yau, TM | 1 |
Lasley, RD | 1 |
Hoshi, K; Ichihara, K; Kano, S; Nakai, T; Satoh, K | 1 |
Fiorillo, C; Formigli, L; Ibba-Manneschi, L; Liguori, P; Nassi, P; Nediani, C; Perna, AM; Rizzuti, G; Zecchi-Orlandini, S | 1 |
Bünger, R; Miki, T; Miura, T; Sakamoto, J; Shimamoto, K; Suzuki, K | 1 |
Hohl, CM | 1 |
del Balzo, U; Flaim, SF; Sun, X; Symons, JD | 1 |
Barends, JP; Bassett, JE; Bassingthwaighte, JB; Gustafson, LA; Kroll, K; van Beek, JH; Zuurbier, CJ | 1 |
Bergeron, R; Caplan, MJ; Ren, J; Russell, RR; Shulman, GI; Sinusas, AJ; Yin, R; Young, LH | 1 |
Obata, T; Yamanaka, Y | 1 |
Beauloye, C; Bertrand, L; Carling, D; Deprez, J; Hue, L; Marsin, AS; Rider, MH; Van den Berghe, G; Vincent, MF | 1 |
Genade, S; Lochner, A; Marais, E; Moolman, JA | 1 |
Beauloye, C; Bertrand, L; Hardie, DG; Hue, L; Krause, U; Marsin, AS; Vanoverschelde, JL | 1 |
5 review(s) available for adenosine monophosphate and Heart Disease, Ischemic
Article | Year |
---|---|
Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data.
Topics: Acute Coronary Syndrome; Adenosine Monophosphate; Aged; Cause of Death; Coronary Disease; Double-Blind Method; Female; Graft Occlusion, Vascular; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stents; Treatment Outcome | 2013 |
[ADP receptor blockers: new insights in the therapy and prophylaxis of ischemic heart disease].
Topics: Acute Coronary Syndrome; Adenosine Monophosphate; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Combined Modality Therapy; Humans; Myocardial Ischemia; Platelet Aggregation Inhibitors; Pyridines; Receptors, Purinergic P2; Stents; Ticlopidine | 2011 |
Advantages of fast-acting ADP receptor blockade in ischemic heart disease.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Animals; Drug Combinations; Humans; Myocardial Ischemia; Platelet Activation; Platelet Aggregation; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Thrombosis; Tissue Plasminogen Activator | 2003 |
Aspirin and clopidogrel resistance: consideration and management.
Topics: Adenosine; Adenosine Monophosphate; Angioplasty, Balloon, Coronary; Aspirin; Clinical Trials as Topic; Clopidogrel; Coronary Restenosis; Drug Resistance; Humans; Membrane Proteins; Myocardial Ischemia; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12; Thiophenes; Ticagrelor; Ticlopidine | 2006 |
Regulation of myocardial glucose uptake and transport during ischemia and energetic stress.
Topics: Adenosine Monophosphate; Adenylate Kinase; Animals; Biological Transport; Exercise; Glucose; Glucose Transporter Type 1; Glucose Transporter Type 4; Humans; Monosaccharide Transport Proteins; Muscle Proteins; Myocardial Ischemia; Myocardium; Oxidative Stress | 1999 |
6 trial(s) available for adenosine monophosphate and Heart Disease, Ischemic
Article | Year |
---|---|
Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPIO
Topics: Adenosine Monophosphate; Aged; Clopidogrel; Coronary Angiography; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Incidence; Infusions, Intravenous; Male; Middle Aged; Myocardial Ischemia; Percutaneous Coronary Intervention; Perioperative Care; Postoperative Complications; Purinergic P2Y Receptor Antagonists; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome; United States | 2018 |
Effect of platelet inhibition with cangrelor during PCI on ischemic events.
Topics: Adenosine Monophosphate; Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Double-Blind Method; Female; Hemorrhage; Humans; Intention to Treat Analysis; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Ischemia; Platelet Aggregation Inhibitors; Stents; Thrombosis; Ticlopidine | 2013 |
The effect of cangrelor and access site on ischaemic and bleeding events: insights from CHAMPION PHOENIX.
Topics: Adenosine Monophosphate; Aged; Clopidogrel; Coronary Thrombosis; Double-Blind Method; Female; Femoral Artery; Graft Occlusion, Vascular; Hemorrhage; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Radial Artery; Stents; Ticlopidine; Treatment Outcome | 2016 |
Reduced immediate ischemic events with cangrelor in PCI: a pooled analysis of the CHAMPION trials using the universal definition of myocardial infarction.
Topics: Adenosine Monophosphate; Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Postoperative Complications; Purinergic P2Y Receptor Antagonists; Survival Rate; Treatment Outcome | 2012 |
Comparison of the pharmacodynamic effects of the platelet ADP receptor antagonists clopidogrel and AR-C69931MX in patients with ischaemic heart disease.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Aged; Clopidogrel; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Purinergic P2 Receptor Antagonists; Ticlopidine | 2002 |
Which techniques of cardioplegia prevent ischemia?
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Blood Flow Velocity; Blood Transfusion, Autologous; Coronary Artery Bypass; Creatine Kinase; Female; Heart; Heart Arrest, Induced; Hemodynamics; Humans; Hydrogen-Ion Concentration; Hypothermia, Induced; Isoenzymes; Lactates; Lactic Acid; Male; Middle Aged; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Oxygen Consumption; Postoperative Period; Temperature; Time Factors; Treatment Outcome | 1993 |
37 other study(ies) available for adenosine monophosphate and Heart Disease, Ischemic
Article | Year |
---|---|
"AMP"(K)ed up recovery from ischemia-reperfusion injury.
Topics: Adenosine Monophosphate; Animals; Humans; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium | 2017 |
Periprocedural Outcomes According to Timing of Clopidogrel Loading Dose in Patients Who Did Not Receive P2Y
Topics: Adenosine Monophosphate; Aged; Clopidogrel; Coronary Thrombosis; Drug Administration Schedule; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Risk Factors; Stents; Time Factors; Treatment Outcome | 2019 |
The duel between dual antiplatelet therapies.
Topics: Adenosine Monophosphate; Angioplasty, Balloon, Coronary; Clopidogrel; Female; Humans; Male; Myocardial Ischemia; Platelet Aggregation Inhibitors; Stents; Thrombosis; Ticlopidine | 2013 |
ACP Journal Club. Cangrelor reduced ischemic PCI complications more than clopidogrel without increasing severe bleeding.
Topics: Adenosine Monophosphate; Angioplasty, Balloon, Coronary; Female; Humans; Male; Myocardial Ischemia; Platelet Aggregation Inhibitors; Stents; Thrombosis; Ticlopidine | 2013 |
Platelet inhibition with cangrelor during PCI.
Topics: Adenosine Monophosphate; Angioplasty, Balloon, Coronary; Female; Humans; Male; Myocardial Ischemia; Platelet Aggregation Inhibitors; Stents; Thrombosis; Ticlopidine | 2013 |
Platelet inhibition with cangrelor during PCI.
Topics: Adenosine Monophosphate; Angioplasty, Balloon, Coronary; Female; Humans; Male; Myocardial Ischemia; Platelet Aggregation Inhibitors; Stents; Thrombosis; Ticlopidine | 2013 |
Cangrelor: a new CHAMPION for percutaneous coronary intervention.
Topics: Adenosine Monophosphate; Female; Humans; Male; Myocardial Ischemia; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors | 2013 |
[Effect of shuangshen ningxin formula on energy metabolism of myocardial ischemia/reperfusion rats].
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Animals; Creatine Kinase, MB Form; Drugs, Chinese Herbal; Energy Metabolism; Humans; Male; Myocardial Ischemia; Myocardial Reperfusion; Rats; Rats, Wistar | 2013 |
Changes in Energy Levels by Dexamethasone in Ischemic Hearts and Brains in Male Mice.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Biogenic Monoamines; Body Temperature; Brain Chemistry; Cardiotonic Agents; Dexamethasone; Energy Metabolism; Enzyme Inhibitors; Injections, Intraperitoneal; Male; Metyrapone; Mice; Muscle, Skeletal; Myocardial Ischemia | 2015 |
Cardioprotective Properties of the Platelet P2Y12 Receptor Inhibitor, Cangrelor: Protective in Diabetics and Reliant Upon the Presence of Blood.
Topics: Adenosine Monophosphate; Animals; Blood Platelets; Cardiotonic Agents; Diabetes Complications; Dose-Response Relationship, Drug; Humans; Male; Mice; Myocardial Ischemia; Myocardial Reperfusion Injury; Purinergic P2Y Receptor Antagonists; Rats; Rats, Inbred Strains; Receptors, Purinergic P2Y12 | 2015 |
Nitric oxide donor, NOC7, reveals biphasic effect on contractile force of isolated rat heart after global ischemia.
Topics: Adenosine Monophosphate; Animals; Glucose; Guanosine Monophosphate; Hydrazines; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Nitric Oxide Donors; Random Allocation; Rats; Rats, Sprague-Dawley; Research Design; Tromethamine | 2008 |
Inhibition of ADP-induced P-selectin expression and platelet-leukocyte conjugate formation by clopidogrel and the P2Y12 receptor antagonist AR-C69931MX but not aspirin.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Aspirin; Blood Platelets; Cell Adhesion; Clopidogrel; Drug Therapy, Combination; Female; Humans; Leukocytes; Male; Membrane Proteins; Middle Aged; Myocardial Ischemia; P-Selectin; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12; Stents; Ticlopidine | 2002 |
Carbon monoxide improves cardiac energetics and safeguards the heart during reperfusion after cardiopulmonary bypass in pigs.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Apoptosis; Carbon Monoxide; Cardiopulmonary Bypass; Cardiotonic Agents; Edema; Electric Countershock; Energy Metabolism; Female; Guanosine Triphosphate; Heart; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocytes, Cardiac; NAD; NADP; Oxidation-Reduction; Sus scrofa | 2004 |
Targeted disruption of cd73/ecto-5'-nucleotidase alters thromboregulation and augments vascular inflammatory response.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Blood Coagulation; Carotid Arteries; Cell Adhesion; Chemotaxis, Leukocyte; Coronary Circulation; Coronary Vessels; Cyclic AMP; Endothelium, Vascular; Extracellular Fluid; Female; Gene Targeting; Inflammation; Ischemia; Leukocytes; Male; Mice; Mice, Knockout; Mice, Transgenic; Muscle, Skeletal; Myocardial Ischemia; Platelet Activation; Receptors, Purinergic P1; Reperfusion | 2004 |
Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases.
Topics: Actins; Adenosine Diphosphate; Adenosine Monophosphate; Adult; Aged; Blood Platelets; Cell Adhesion Molecules; Clopidogrel; Dose-Response Relationship, Drug; Drug Resistance; Female; Flow Cytometry; Humans; Male; Membrane Proteins; Microfilament Proteins; Middle Aged; Myocardial Ischemia; Phosphoproteins; Phosphorylation; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Ticlopidine; Time Factors | 2005 |
Dual mechanisms regulating AMPK kinase action in the ischemic heart.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Aminoimidazole Carboxamide; AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Animals; Infusions, Intravenous; Male; Multienzyme Complexes; Myocardial Ischemia; Myocardium; Phosphorylation; Protein Kinases; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Ribonucleotides | 2005 |
Deficiency of LKB1 in heart prevents ischemia-mediated activation of AMPKalpha2 but not AMPKalpha1.
Topics: Acetyl-CoA Carboxylase; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; AMP-Activated Protein Kinases; Animals; Body Weight; Electrocardiography; Enzyme Activation; Heart; Mice; Mice, Inbred C57BL; Mice, Knockout; Multienzyme Complexes; Myocardial Ischemia; Myocardium; Myocytes, Cardiac; Organ Size; Perfusion; Phosphorylation; Protein Serine-Threonine Kinases; Protein Subunits | 2006 |
Insulin antagonizes ischemia-induced Thr172 phosphorylation of AMP-activated protein kinase alpha-subunits in heart via hierarchical phosphorylation of Ser485/491.
Topics: Adenosine Monophosphate; AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Animals; Enzyme Activation; In Vitro Techniques; Insulin; Male; Multienzyme Complexes; Myocardial Ischemia; Myocardium; Phosphorylation; Protein Serine-Threonine Kinases; Protein Subunits; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Serine; Threonine | 2006 |
Metabolomic identification of novel biomarkers of myocardial ischemia.
Topics: Adenosine Monophosphate; Aged; Biomarkers; Case-Control Studies; Chromatography, High Pressure Liquid; Citric Acid; Exercise Test; Female; Humans; Lactic Acid; Male; Metabolism; Middle Aged; Muscle, Skeletal; Myocardial Ischemia; Risk; Spectrometry, Mass, Electrospray Ionization | 2005 |
Modeling transmural heterogeneity of K(ATP) current in rabbit ventricular myocytes.
Topics: Action Potentials; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; ATP-Binding Cassette Transporters; Calcium; Calcium Channels, L-Type; Computer Simulation; Creatine; Endocardium; Heart Ventricles; Hydrogen-Ion Concentration; Ion Channel Gating; Magnesium; Models, Cardiovascular; Myocardial Ischemia; Myocytes, Cardiac; Pericardium; Phosphocreatine; Potassium; Potassium Channels; Potassium Channels, Inwardly Rectifying; Rabbits; Receptors, Drug; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Signal Transduction; Sodium-Potassium-Exchanging ATPase; Sulfonylurea Receptors | 2007 |
Defective metabolic signaling in adenylate kinase AK1 gene knock-out hearts compromises post-ischemic coronary reflow.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Adenylate Kinase; Animals; Creatine Kinase; Energy Metabolism; Gene Deletion; Heart; Isoenzymes; Mice; Mice, Knockout; Models, Biological; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Myocytes, Cardiac; Nuclear Magnetic Resonance, Biomolecular; Oxygen Isotopes; Phosphoproteins; Phosphorus Isotopes; Signal Transduction | 2007 |
Ischemia-induced activation of AMPK does not increase glucose uptake in glycogen-replete isolated working rat hearts.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Aerobiosis; Animals; Cell Membrane; Creatine; Cyclic AMP-Dependent Protein Kinases; Energy Metabolism; Enzyme Activation; Fatty Acids; Glucose; Glucose Transporter Type 4; Glycogen; Glycolysis; Hypoglycemic Agents; In Vitro Techniques; Insulin; Male; Myocardial Ischemia; Myocardium; Phosphocreatine; Rats; Rats, Sprague-Dawley; Sarcolemma; Ventricular Function, Left | 2008 |
Protection against injury during ischemia and reperfusion by acadesine derivatives GP-1-468 and GP-1-668. Studies in the transplanted rat heart.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Aminoimidazole Carboxamide; Animals; Coronary Circulation; Heart Transplantation; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Inbred Lew; Ribonucleosides; Ribonucleotides; Ventricular Pressure | 1995 |
Intermittent v continuous ischemia decelerates adenylate breakdown and prevents norepinephrine release in reperfused rabbit heart.
Topics: Adenine Nucleotides; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Analysis of Variance; Animals; Heart; Hypoxanthine; Hypoxanthines; In Vitro Techniques; Kinetics; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Norepinephrine; Purines; Rabbits; Time Factors; Ventricular Function, Left | 1995 |
Enhancement of ischemic myocardial metabolic derangement by glibenclamide.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Animals; Blood Glucose; Blood Pressure; Disease Models, Animal; Dogs; Energy Metabolism; Female; Fructosephosphates; Glucose-6-Phosphate; Glucosephosphates; Glyburide; Heart; Heart Rate; Insulin; Male; Myocardial Ischemia; Myocardium; Phosphocreatine; Potassium Channels | 1994 |
Does the severity of acute hypoxia influence neonatal myocardial metabolism and sensitivity to ischemia?
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Animals, Newborn; Blood Gas Analysis; Glycogen; Hypoxia; Inosine Monophosphate; Lactates; Male; Myocardial Ischemia; Myocardium; Phosphocreatine; Severity of Illness Index; Swine; Time Factors | 1994 |
Ischemic preconditioning and adenosine release.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Dogs; Myocardial Ischemia; Receptors, Purinergic | 1993 |
Effects of adenine nucleotide analogues on myocardial dysfunction during reperfusion after ischemia in dogs.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenine Nucleotides; Adenosine Monophosphate; Aminoimidazole Carboxamide; Animals; Carbohydrate Metabolism; Cardiomyopathies; Coronary Circulation; Dogs; Female; Hemodynamics; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Ribonucleotides | 1996 |
Beneficial effects of the 21-aminosteroid U 74389G on the ischemia-reperfusion damage in pig hearts.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Antioxidants; Female; Hemodynamics; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Pregnatrienes; Swine | 1997 |
Ecto-5'-nucleotidase is not required for ischemic preconditioning in rabbit myocardium in situ.
Topics: 5'-Nucleotidase; Adenosine Diphosphate; Adenosine Monophosphate; Animals; Blood Pressure; Enzyme Inhibitors; Heart; Heart Rate; Ischemic Preconditioning; Male; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Purinergic P1 Receptor Antagonists; Rabbits; Theophylline | 1998 |
AMP deaminase in piglet cardiac myocytes: effect on nucleotide metabolism during ischemia.
Topics: 1-Methyl-3-isobutylxanthine; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; AMP Deaminase; Animals; Animals, Newborn; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carcinogens; Carotenoids; Cells, Cultured; Cyclic AMP; Energy Metabolism; Enzyme Activation; Heart Ventricles; Ischemic Preconditioning; Muscle Fibers, Skeletal; Myocardial Ischemia; Myocardium; Oxygenases; Phosphodiesterase Inhibitors; Swine; Tetradecanoylphorbol Acetate; Uncoupling Agents | 1999 |
Perflubron emulsion improves tolerance to low-flow ischemia in isolated rabbit hearts.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Coronary Vessels; Fluorocarbons; Heart; Hemodynamics; Hydrocarbons, Brominated; In Vitro Techniques; Lactic Acid; Myocardial Ischemia; Myocardium; Oxygen; Perfusion; Phosphates; Rabbits | 1999 |
Increased hypoxic stress decreases AMP hydrolysis in rabbit heart.
Topics: Adenosine; Adenosine Monophosphate; Analysis of Variance; Animals; Computer Simulation; Hydrolysis; Magnetic Resonance Spectroscopy; Models, Cardiovascular; Myocardial Ischemia; Myocardium; Perfusion; Purines; Rabbits; Time Factors | 1999 |
An increase of the native interstitial adenosine concentration during histidine application.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Monophosphate; Animals; Dialysis Solutions; Histidine; Male; Microdialysis; Myocardial Ischemia; Myocardium; Norepinephrine; Rats; Rats, Wistar; Reactive Oxygen Species; Reperfusion Injury | 2000 |
Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; AMP-Activated Protein Kinases; Animals; Cell Line; Energy Metabolism; Enzyme Activation; Glycolysis; Humans; Kinetics; Male; Multienzyme Complexes; Myocardial Ischemia; Myocardium; Phosphofructokinase-2; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Protein Serine-Threonine Kinases; Rats; Rats, Wistar; Recombinant Proteins; Transfection | 2000 |
Nitric oxide: a trigger for classic preconditioning?
Topics: Adenosine Monophosphate; Animals; Cyclic GMP; Enzyme Inhibitors; Epinephrine; Guanylate Cyclase; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Male; Myocardial Contraction; Myocardial Ischemia; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroarginine; Nitroprusside; Oxadiazoles; Penicillamine; Quinoxalines; Rats; Rats, Wistar; S-Nitroso-N-Acetylpenicillamine; Sympathomimetics; Vasodilator Agents | 2000 |
Insulin antagonizes AMP-activated protein kinase activation by ischemia or anoxia in rat hearts, without affecting total adenine nucleotides.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; AMP-Activated Protein Kinases; Animals; Cell Hypoxia; Enzyme Activation; Enzyme Inhibitors; Insulin; Male; Multienzyme Complexes; Myocardial Ischemia; Myocardium; Protein Serine-Threonine Kinases; Rats; Rats, Wistar | 2001 |